Abbate, V.; Barone, S.; Troise, S.; Laface, C.; Bonavolontà , P.; Pacella, D.; Salzano, G.; Iaconetta, G.; Califano, L.; Dell’Aversana Orabona, G.
The Combination of Inflammatory Biomarkers as Prognostic Indicator in Salivary Gland Malignancy. Cancers 2022, 14, 5934.
https://doi.org/10.3390/cancers14235934
AMA Style
Abbate V, Barone S, Troise S, Laface C, Bonavolontà P, Pacella D, Salzano G, Iaconetta G, Califano L, Dell’Aversana Orabona G.
The Combination of Inflammatory Biomarkers as Prognostic Indicator in Salivary Gland Malignancy. Cancers. 2022; 14(23):5934.
https://doi.org/10.3390/cancers14235934
Chicago/Turabian Style
Abbate, Vincenzo, Simona Barone, Stefania Troise, Claudia Laface, Paola Bonavolontà , Daniela Pacella, Giovanni Salzano, Giorgio Iaconetta, Luigi Califano, and Giovanni Dell’Aversana Orabona.
2022. "The Combination of Inflammatory Biomarkers as Prognostic Indicator in Salivary Gland Malignancy" Cancers 14, no. 23: 5934.
https://doi.org/10.3390/cancers14235934
APA Style
Abbate, V., Barone, S., Troise, S., Laface, C., Bonavolontà , P., Pacella, D., Salzano, G., Iaconetta, G., Califano, L., & Dell’Aversana Orabona, G.
(2022). The Combination of Inflammatory Biomarkers as Prognostic Indicator in Salivary Gland Malignancy. Cancers, 14(23), 5934.
https://doi.org/10.3390/cancers14235934